TY - JOUR
KW - Buprenorphine/therapeutic use
KW - Drug Prescriptions
KW - Humans
KW - Legislation, Drug
KW - Narcotic Antagonists/therapeutic use
KW - Nurse Practitioners
KW - Opioid-Related Disorders/drug therapy
AU - Katherine S. Fornili
AU - Susanne A. Fogger
A1 - 
AB - The aim of this Policy Watch column is to provide an update on a much anticipated legislation, enacted in 2016, which enabled office-based opioid treatment (OBOT) with buprenorphine prescribing for the treatment of opioid addiction by nurse practitioners (as well as physician assistants). First, an overview of the Drug Addiction Treatment Act of 2000, which only permitted OBOT prescribing by physicians, will be described. It will be followed by a summary of the Recovery Enhancement for Addiction Treatment Act of 2015-2016. Finally, a review of the Comprehensive Addiction Recovery Act of 2016 will be provided, which includes information about important changes to OBOT regulations that enable NP prescribing of buprenorphine for the treatment of opioid addiction.
AD - Katherine S. Fornili, DNP, MPH, RN, CARN, FIAAN, University of Maryland School of Nursing, Baltimore. Susanne A. Fogger, DNP, CRNP, PMHNP-BC, CARN-AP, FAANP, School of Nursing, University of Alabama at Birmingham.
BT - Journal of addictions nursing
C5 - Education & Workforce; Healthcare Policy; Opioids & Substance Use
CP - 1
CY - United States
DO - 10.1097/JAN.0000000000000160
IS - 1
JF - Journal of addictions nursing
LA - eng
M1 - Journal Article
N2 - The aim of this Policy Watch column is to provide an update on a much anticipated legislation, enacted in 2016, which enabled office-based opioid treatment (OBOT) with buprenorphine prescribing for the treatment of opioid addiction by nurse practitioners (as well as physician assistants). First, an overview of the Drug Addiction Treatment Act of 2000, which only permitted OBOT prescribing by physicians, will be described. It will be followed by a summary of the Recovery Enhancement for Addiction Treatment Act of 2015-2016. Finally, a review of the Comprehensive Addiction Recovery Act of 2016 will be provided, which includes information about important changes to OBOT regulations that enable NP prescribing of buprenorphine for the treatment of opioid addiction.
PP - United States
PY - 2017
SN - 1548-7148; 1088-4602
SP - 43
EP - 48
EP - 
T1 - Nurse Practitioner Prescriptive Authority for Buprenorphine: From DATA 2000 to CARA 2016
T2 - Journal of addictions nursing
TI - Nurse Practitioner Prescriptive Authority for Buprenorphine: From DATA 2000 to CARA 2016
U1 - Education & Workforce; Healthcare Policy; Opioids & Substance Use
U2 - 28252511
U3 - 10.1097/JAN.0000000000000160
VL - 28
VO - 1548-7148; 1088-4602
Y1 - 2017
Y2 - Jan/Mar
ER -